AVISTA HEALTHCARE PARTNERS SIGNS DEFINITIVE AGREEMENT TO ACQUIRE SANOTACT GROUP

Avista Healthcare Partners, a prominent private equity firm specializing in healthcare investments, has entered into a definitive agreement to acquire sanotact Group GmbH, a leading German platform in the vitamins, minerals, and supplements (VMS) sector. The deal, which also includes Damier Group as a strategic co-investor alongside existing investor FLOTTE Beteiligungen GmbH, is valued at an undisclosed amount and is subject to regulatory approval. This acquisition marks a significant move for Avista as it continues to expand its portfolio in the consumer healthcare space.

Founded in 2005, Avista Healthcare Partners has a strong track record of investing in growth-oriented healthcare businesses. The firm has invested over $10 billion across more than 50 companies globally, focusing on businesses with robust growth potential and strong management teams. The acquisition of sanotact aligns with Avista's strategy of targeting companies that are well-positioned to benefit from prevailing market trends, particularly the increasing consumer emphasis on preventative health and wellness.

Sanotact, headquartered in Münster, Germany, has established itself as a trusted player in the VMS market through its innovative product offerings and high-quality manufacturing capabilities. The company operates a diversified business model that includes a full-service contract development and manufacturing organization (CDMO) platform and a portfolio of branded VMS products, including its flagship sanotact® brand. Serving customers across 80 international markets, sanotact has built a strong reputation as an innovation partner for leading drugstores and distributors.

The strategic rationale behind this acquisition is underscored by the growing consumer shift towards self-care and preventative health solutions, particularly in Europe. Yvan Vindevogel, Founder of Damier Group, noted that sanotact's understanding of customer needs positions the company well to capitalize on these long-term health trends. The partnership with Avista and FLOTTE is expected to enhance sanotact's innovation capabilities and expand its international footprint, thereby driving further growth.

As the healthcare sector continues to evolve, this acquisition highlights the increasing interest in consumer health products, particularly in the VMS segment. The collaboration between Avista, Damier, and FLOTTE is indicative of a broader trend where private equity firms are actively seeking opportunities to invest in companies that align with changing consumer preferences. The successful integration of sanotact into Avista's portfolio may set a precedent for future investments in the healthcare space, particularly as the demand for high-quality health products continues to rise.